Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,105
Closed -$237K 2285
2025
Q3
$237K Buy
16,105
+460
+3% +$4.69K ﹤0.01% 2172
2025
Q2
$154K Buy
+15,645
New +$130K ﹤0.01% 2248
2024
Q4
Sell
-21,815
Closed -$161K 2388
2024
Q3
$161K Buy
21,815
+2,340
+12% +$19.7K ﹤0.01% 2538
2024
Q2
$156K Sell
19,475
-136
-0.7% -$1.21K ﹤0.01% 2511
2024
Q1
$228K Sell
19,611
-9,285
-32% -$103K ﹤0.01% 2434
2023
Q4
$323K Buy
+28,896
New +$266K ﹤0.01% 2291

Other funds holding ETNB

Prudential Financial's ETNB Position: Q4 2025 in Review

Prudential Financial sold out of 89bio (ETNB) in Q4 2025, closing a stake of 16,105 shares — an estimated $237K sold.

Prudential Financial first reported a position in ETNB in Q4 2023 and held it in 6 quarters. The position peaked at $323K in Q4 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Prudential Financial reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Prudential Financial sold 16,105 89bio shares in Q4 2025, an estimated $237K.
  • Prudential Financial first reported a position in 89bio in Q4 2023 and held it in 6 quarters.
  • Prudential Financial's 89bio position peaked at $323K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Prudential Financial's 13F filing for Q4 2025, filed 13 Feb 2026.